SEC INSIDER TRANSACTIONS

BIO-TECHNE Corp (TECH) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

TECH · BIO-TECHNE Corp

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 32 filings · fetched 2026-11-13T20:19:21Z

Recent reported activity

0purchase rows on this page

0sale rows on this page

115matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-08-15Filed 2026-08-18	Hippel JamesOfficer · CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 866 performance RSUs. The remainder of the performance RSUs were forfeited. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,332 performance options. The remainder of the performance options were forfeited. F5 Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F8 Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028. F9 11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027. F10 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. F12 Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F2, F3	M Exercise / conversionPerformance Restricted Stock Units · Derivative	866D	0	Direct	Form 4 ↗0000914190-26-000121
2026-08-15Filed 2026-08-18	Hippel JamesOfficer · CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 866 performance RSUs. The remainder of the performance RSUs were forfeited. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,332 performance options. The remainder of the performance options were forfeited. F5 Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F8 Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028. F9 11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027. F10 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. F12 Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References:	F WithholdingCommon Stock · Non-derivative	4,310D	72.4	Direct	Form 4 ↗0000914190-26-000121
2026-08-15Filed 2026-08-18	Hippel JamesOfficer · CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 866 performance RSUs. The remainder of the performance RSUs were forfeited. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,332 performance options. The remainder of the performance options were forfeited. F5 Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F8 Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028. F9 11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027. F10 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. F12 Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References:	M Exercise / conversionCommon Stock · Non-derivative	9,779A	0	Direct	Form 4 ↗0000914190-26-000121
2026-08-15Filed 2026-08-18	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F2 100% vested. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 567 performance RSUs. The remainder of the performance RSUs were forfeited. F4 Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,526 performance options. The remainder of the performance options were forfeited. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 2,623 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F8 Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F9 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F10 3,226 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F11 Options to purchase 8,253 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,252 shares vest on 8/15/2028. References: F1, F10	M Exercise / conversionRestricted Stock Units · Derivative	3,226D	0	Direct	Form 4 ↗0000914190-26-000120
2026-08-15Filed 2026-08-18	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F2 100% vested. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 567 performance RSUs. The remainder of the performance RSUs were forfeited. F4 Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,526 performance options. The remainder of the performance options were forfeited. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 2,623 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F8 Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F9 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F10 3,226 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F11 Options to purchase 8,253 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,252 shares vest on 8/15/2028. References: F1, F7	M Exercise / conversionRestricted Stock Units · Derivative	2,623D	0	Direct	Form 4 ↗0000914190-26-000120
2026-08-15Filed 2026-08-18	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F2 100% vested. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 567 performance RSUs. The remainder of the performance RSUs were forfeited. F4 Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,526 performance options. The remainder of the performance options were forfeited. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 2,623 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F8 Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F9 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F10 3,226 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F11 Options to purchase 8,253 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,252 shares vest on 8/15/2028. References: F5	D Other reported codePerformance Stock Options (Right to Buy) · Derivative	22,898D	0	Direct	Form 4 ↗0000914190-26-000120
2026-08-15Filed 2026-08-18	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F2 100% vested. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 567 performance RSUs. The remainder of the performance RSUs were forfeited. F4 Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,526 performance options. The remainder of the performance options were forfeited. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 2,623 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F8 Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F9 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F10 3,226 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F11 Options to purchase 8,253 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,252 shares vest on 8/15/2028. References: F1, F3	D Other reported codePerformance Restricted Stock Units · Derivative	8,507D	0	Direct	Form 4 ↗0000914190-26-000120
2026-08-15Filed 2026-08-18	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F2 100% vested. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 567 performance RSUs. The remainder of the performance RSUs were forfeited. F4 Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,526 performance options. The remainder of the performance options were forfeited. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 2,623 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F8 Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F9 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F10 3,226 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F11 Options to purchase 8,253 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,252 shares vest on 8/15/2028. References: F1, F3	M Exercise / conversionPerformance Restricted Stock Units · Derivative	567D	0	Direct	Form 4 ↗0000914190-26-000120
2026-08-15Filed 2026-08-18	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F2 100% vested. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 567 performance RSUs. The remainder of the performance RSUs were forfeited. F4 Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,526 performance options. The remainder of the performance options were forfeited. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 2,623 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F8 Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F9 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F10 3,226 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F11 Options to purchase 8,253 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,252 shares vest on 8/15/2028. References:	F WithholdingCommon Stock · Non-derivative	1,976D	72.4	Direct	Form 4 ↗0000914190-26-000120
2026-08-15Filed 2026-08-18	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F2 100% vested. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 567 performance RSUs. The remainder of the performance RSUs were forfeited. F4 Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,526 performance options. The remainder of the performance options were forfeited. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 2,623 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F8 Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F9 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F10 3,226 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F11 Options to purchase 8,253 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,252 shares vest on 8/15/2028. References:	M Exercise / conversionCommon Stock · Non-derivative	6,416A	0	Direct	Form 4 ↗0000914190-26-000120
2026-08-15Filed 2026-08-18	Bohnen ShaneOfficer · SVP - General Counsel Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027. F5 49 restricted stock units vest on 8/15/2026. F6 On 8/15/2026, the Board of Directors authorized discretionary vesting for 807 performance options. The remainder of the performance options were forfeited. F7 On 8/15/2026, the Board of Directors authorized discretionary vesting for 300 performance RSUs. The remainder of the performance RSUs were forfeited. F8 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F9 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F10 Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F11 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F12 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F13 Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028. References: F3, F12	M Exercise / conversionRestricted Stock Units · Derivative	2,332D	0	Direct	Form 4 ↗0000914190-26-000116
2026-08-15Filed 2026-08-18	Bohnen ShaneOfficer · SVP - General Counsel Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027. F5 49 restricted stock units vest on 8/15/2026. F6 On 8/15/2026, the Board of Directors authorized discretionary vesting for 807 performance options. The remainder of the performance options were forfeited. F7 On 8/15/2026, the Board of Directors authorized discretionary vesting for 300 performance RSUs. The remainder of the performance RSUs were forfeited. F8 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F9 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F10 Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F11 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F12 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F13 Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028. References: F3, F9	M Exercise / conversionRestricted Stock Units · Derivative	1,669D	0	Direct	Form 4 ↗0000914190-26-000116
2026-08-15Filed 2026-08-18	Bohnen ShaneOfficer · SVP - General Counsel Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027. F5 49 restricted stock units vest on 8/15/2026. F6 On 8/15/2026, the Board of Directors authorized discretionary vesting for 807 performance options. The remainder of the performance options were forfeited. F7 On 8/15/2026, the Board of Directors authorized discretionary vesting for 300 performance RSUs. The remainder of the performance RSUs were forfeited. F8 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F9 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F10 Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F11 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F12 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F13 Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028. References: F3, F7	D Other reported codePerformance Restricted Stock Units · Derivative	4,502D	0	Direct	Form 4 ↗0000914190-26-000116
2026-08-15Filed 2026-08-18	Bohnen ShaneOfficer · SVP - General Counsel Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027. F5 49 restricted stock units vest on 8/15/2026. F6 On 8/15/2026, the Board of Directors authorized discretionary vesting for 807 performance options. The remainder of the performance options were forfeited. F7 On 8/15/2026, the Board of Directors authorized discretionary vesting for 300 performance RSUs. The remainder of the performance RSUs were forfeited. F8 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F9 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F10 Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F11 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F12 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F13 Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028. References: F3, F7	M Exercise / conversionPerformance Restricted Stock Units · Derivative	300D	0	Direct	Form 4 ↗0000914190-26-000116
2026-08-15Filed 2026-08-18	Bohnen ShaneOfficer · SVP - General Counsel Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027. F5 49 restricted stock units vest on 8/15/2026. F6 On 8/15/2026, the Board of Directors authorized discretionary vesting for 807 performance options. The remainder of the performance options were forfeited. F7 On 8/15/2026, the Board of Directors authorized discretionary vesting for 300 performance RSUs. The remainder of the performance RSUs were forfeited. F8 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F9 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F10 Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F11 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F12 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F13 Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028. References: F6	D Other reported codePerformance Stock Option (Right to Buy) · Derivative	12,117D	0	Direct	Form 4 ↗0000914190-26-000116
2026-08-15Filed 2026-08-18	Bohnen ShaneOfficer · SVP - General Counsel Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027. F5 49 restricted stock units vest on 8/15/2026. F6 On 8/15/2026, the Board of Directors authorized discretionary vesting for 807 performance options. The remainder of the performance options were forfeited. F7 On 8/15/2026, the Board of Directors authorized discretionary vesting for 300 performance RSUs. The remainder of the performance RSUs were forfeited. F8 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F9 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F10 Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F11 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F12 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F13 Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028. References: F3, F5	M Exercise / conversionRestricted Stock Units · Derivative	49D	0	Direct	Form 4 ↗0000914190-26-000116
2026-08-15Filed 2026-08-18	Bohnen ShaneOfficer · SVP - General Counsel Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027. F5 49 restricted stock units vest on 8/15/2026. F6 On 8/15/2026, the Board of Directors authorized discretionary vesting for 807 performance options. The remainder of the performance options were forfeited. F7 On 8/15/2026, the Board of Directors authorized discretionary vesting for 300 performance RSUs. The remainder of the performance RSUs were forfeited. F8 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F9 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F10 Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F11 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F12 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F13 Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028. References:	F WithholdingCommon Stock · Non-derivative	1,343D	72.4	Direct	Form 4 ↗0000914190-26-000116
2026-08-15Filed 2026-08-18	Bohnen ShaneOfficer · SVP - General Counsel Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027. F5 49 restricted stock units vest on 8/15/2026. F6 On 8/15/2026, the Board of Directors authorized discretionary vesting for 807 performance options. The remainder of the performance options were forfeited. F7 On 8/15/2026, the Board of Directors authorized discretionary vesting for 300 performance RSUs. The remainder of the performance RSUs were forfeited. F8 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F9 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F10 Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F11 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F12 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F13 Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028. References:	M Exercise / conversionCommon Stock · Non-derivative	4,350A	0	Direct	Form 4 ↗0000914190-26-000116
2026-08-15Filed 2026-08-18	Crouse Steven C.Officer · President - Diag & Spatial Bi Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F2 794 restricted stock units vest on 5/1/2027. F3 600 restricted stock units vest on each of 6/2/2027 and 6/2/2028. F4 1,379 restricted stock units vest on 8/15/2026. F5 1,868 restricted stock units vest on 8/15/2026 and 1,869 restricted stock units vest on 8/15/2027. F6 2,176 restricted stock units vest on each of 8/15/2026 and 8/15/2028; and 2,177 restricted stock units vest on 8/15/2027. F7 100% vested. F8 Options to purchase 6,140 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026. F9 Options to purchase 3,162 shares vest on each of 8/15/2024, 8/15/2026 and 8/15/2027; and options to purchase 3,163 shares vest on 8/15/2025. F10 Options to purchase 1,832 shares vest on each of 5/1/2025, 5/1/2026 and 5/1/2028; and options to purchase 1,831 shares vest on 5/1/2027. F11 Options to purchase 4,283 shares vest on each of 8/15/2025, 8/15/2027 and 8/15/2028; and options to purchase 4,284 shares vest on 8/15/2026. F12 Options to purchase 1,359 shares vest on each of 6/2/2026 and 6/2/2028; and options to purchase 1,358 shares vest on each of 6/2/2027 and 6/2/2029. F13 Options to purchase 4,788 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2029; and options to purchase 4,787 shares vest on 8/15/2028. F14 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F15 245 restricted stock units vest on 3/2/2027, 3/2/2028 and 3/2/2029. F16 Options to purchase 478 shares vest on each of 3/2/2027, 3/2/2028 and 3/2/2030; and options to purchase 477 shares vest on 3/2/2029. References: F1, F6	M Exercise / conversionRestricted Stock Units · Derivative	2,176D	0	Direct	Form 4 ↗0000914190-26-000114
2026-08-15Filed 2026-08-18	Crouse Steven C.Officer · President - Diag & Spatial Bi Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F2 794 restricted stock units vest on 5/1/2027. F3 600 restricted stock units vest on each of 6/2/2027 and 6/2/2028. F4 1,379 restricted stock units vest on 8/15/2026. F5 1,868 restricted stock units vest on 8/15/2026 and 1,869 restricted stock units vest on 8/15/2027. F6 2,176 restricted stock units vest on each of 8/15/2026 and 8/15/2028; and 2,177 restricted stock units vest on 8/15/2027. F7 100% vested. F8 Options to purchase 6,140 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026. F9 Options to purchase 3,162 shares vest on each of 8/15/2024, 8/15/2026 and 8/15/2027; and options to purchase 3,163 shares vest on 8/15/2025. F10 Options to purchase 1,832 shares vest on each of 5/1/2025, 5/1/2026 and 5/1/2028; and options to purchase 1,831 shares vest on 5/1/2027. F11 Options to purchase 4,283 shares vest on each of 8/15/2025, 8/15/2027 and 8/15/2028; and options to purchase 4,284 shares vest on 8/15/2026. F12 Options to purchase 1,359 shares vest on each of 6/2/2026 and 6/2/2028; and options to purchase 1,358 shares vest on each of 6/2/2027 and 6/2/2029. F13 Options to purchase 4,788 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2029; and options to purchase 4,787 shares vest on 8/15/2028. F14 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F15 245 restricted stock units vest on 3/2/2027, 3/2/2028 and 3/2/2029. F16 Options to purchase 478 shares vest on each of 3/2/2027, 3/2/2028 and 3/2/2030; and options to purchase 477 shares vest on 3/2/2029. References: F1, F5	M Exercise / conversionRestricted Stock Units · Derivative	1,868D	0	Direct	Form 4 ↗0000914190-26-000114
2026-08-15Filed 2026-08-18	Crouse Steven C.Officer · President - Diag & Spatial Bi Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F2 794 restricted stock units vest on 5/1/2027. F3 600 restricted stock units vest on each of 6/2/2027 and 6/2/2028. F4 1,379 restricted stock units vest on 8/15/2026. F5 1,868 restricted stock units vest on 8/15/2026 and 1,869 restricted stock units vest on 8/15/2027. F6 2,176 restricted stock units vest on each of 8/15/2026 and 8/15/2028; and 2,177 restricted stock units vest on 8/15/2027. F7 100% vested. F8 Options to purchase 6,140 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026. F9 Options to purchase 3,162 shares vest on each of 8/15/2024, 8/15/2026 and 8/15/2027; and options to purchase 3,163 shares vest on 8/15/2025. F10 Options to purchase 1,832 shares vest on each of 5/1/2025, 5/1/2026 and 5/1/2028; and options to purchase 1,831 shares vest on 5/1/2027. F11 Options to purchase 4,283 shares vest on each of 8/15/2025, 8/15/2027 and 8/15/2028; and options to purchase 4,284 shares vest on 8/15/2026. F12 Options to purchase 1,359 shares vest on each of 6/2/2026 and 6/2/2028; and options to purchase 1,358 shares vest on each of 6/2/2027 and 6/2/2029. F13 Options to purchase 4,788 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2029; and options to purchase 4,787 shares vest on 8/15/2028. F14 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F15 245 restricted stock units vest on 3/2/2027, 3/2/2028 and 3/2/2029. F16 Options to purchase 478 shares vest on each of 3/2/2027, 3/2/2028 and 3/2/2030; and options to purchase 477 shares vest on 3/2/2029. References: F1, F4	M Exercise / conversionRestricted Stock Units · Derivative	1,379D	0	Direct	Form 4 ↗0000914190-26-000114
2026-08-15Filed 2026-08-18	Crouse Steven C.Officer · President - Diag & Spatial Bi Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F2 794 restricted stock units vest on 5/1/2027. F3 600 restricted stock units vest on each of 6/2/2027 and 6/2/2028. F4 1,379 restricted stock units vest on 8/15/2026. F5 1,868 restricted stock units vest on 8/15/2026 and 1,869 restricted stock units vest on 8/15/2027. F6 2,176 restricted stock units vest on each of 8/15/2026 and 8/15/2028; and 2,177 restricted stock units vest on 8/15/2027. F7 100% vested. F8 Options to purchase 6,140 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026. F9 Options to purchase 3,162 shares vest on each of 8/15/2024, 8/15/2026 and 8/15/2027; and options to purchase 3,163 shares vest on 8/15/2025. F10 Options to purchase 1,832 shares vest on each of 5/1/2025, 5/1/2026 and 5/1/2028; and options to purchase 1,831 shares vest on 5/1/2027. F11 Options to purchase 4,283 shares vest on each of 8/15/2025, 8/15/2027 and 8/15/2028; and options to purchase 4,284 shares vest on 8/15/2026. F12 Options to purchase 1,359 shares vest on each of 6/2/2026 and 6/2/2028; and options to purchase 1,358 shares vest on each of 6/2/2027 and 6/2/2029. F13 Options to purchase 4,788 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2029; and options to purchase 4,787 shares vest on 8/15/2028. F14 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F15 245 restricted stock units vest on 3/2/2027, 3/2/2028 and 3/2/2029. F16 Options to purchase 478 shares vest on each of 3/2/2027, 3/2/2028 and 3/2/2030; and options to purchase 477 shares vest on 3/2/2029. References:	F WithholdingCommon Stock · Non-derivative	1,947D	72.4	Direct	Form 4 ↗0000914190-26-000114
2026-08-15Filed 2026-08-18	Crouse Steven C.Officer · President - Diag & Spatial Bi Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F2 794 restricted stock units vest on 5/1/2027. F3 600 restricted stock units vest on each of 6/2/2027 and 6/2/2028. F4 1,379 restricted stock units vest on 8/15/2026. F5 1,868 restricted stock units vest on 8/15/2026 and 1,869 restricted stock units vest on 8/15/2027. F6 2,176 restricted stock units vest on each of 8/15/2026 and 8/15/2028; and 2,177 restricted stock units vest on 8/15/2027. F7 100% vested. F8 Options to purchase 6,140 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026. F9 Options to purchase 3,162 shares vest on each of 8/15/2024, 8/15/2026 and 8/15/2027; and options to purchase 3,163 shares vest on 8/15/2025. F10 Options to purchase 1,832 shares vest on each of 5/1/2025, 5/1/2026 and 5/1/2028; and options to purchase 1,831 shares vest on 5/1/2027. F11 Options to purchase 4,283 shares vest on each of 8/15/2025, 8/15/2027 and 8/15/2028; and options to purchase 4,284 shares vest on 8/15/2026. F12 Options to purchase 1,359 shares vest on each of 6/2/2026 and 6/2/2028; and options to purchase 1,358 shares vest on each of 6/2/2027 and 6/2/2029. F13 Options to purchase 4,788 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2029; and options to purchase 4,787 shares vest on 8/15/2028. F14 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F15 245 restricted stock units vest on 3/2/2027, 3/2/2028 and 3/2/2029. F16 Options to purchase 478 shares vest on each of 3/2/2027, 3/2/2028 and 3/2/2030; and options to purchase 477 shares vest on 3/2/2029. References:	M Exercise / conversionCommon Stock · Non-derivative	5,423A	0	Direct	Form 4 ↗0000914190-26-000114
2026-08-15Filed 2026-08-18	Herr Amy E.Director Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders. F2 Fully vested. F3 Options to purchase 528 shares vest on 8/15/2023 and 8/15/2025; and options to purchase 524 shares vest on 8/15/2024 and 8/15/2026. F4 Options to purchase 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027. F5 Options to purchase 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F6 Options to purchase 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029. F7 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F8 118 restricted stock units vest on 8/15/2026. F9 160 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F10 38 restricted stock units vest on 2/3/2027 and 39 restricted stock units vest on 2/3/2028. F11 311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028. F12 Options to purchase 912 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 911 shares vest on 8/15/2028. References: F7, F11	M Exercise / conversionRestricted Stock Units · Derivative	311D	0	IndirectBy significant other	Form 4 ↗0000914190-26-000113
2026-08-15Filed 2026-08-18	Herr Amy E.Director Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders. F2 Fully vested. F3 Options to purchase 528 shares vest on 8/15/2023 and 8/15/2025; and options to purchase 524 shares vest on 8/15/2024 and 8/15/2026. F4 Options to purchase 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027. F5 Options to purchase 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F6 Options to purchase 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029. F7 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F8 118 restricted stock units vest on 8/15/2026. F9 160 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F10 38 restricted stock units vest on 2/3/2027 and 39 restricted stock units vest on 2/3/2028. F11 311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028. F12 Options to purchase 912 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 911 shares vest on 8/15/2028. References: F7, F9	M Exercise / conversionRestricted Stock Units · Derivative	160D	0	IndirectBy significant other	Form 4 ↗0000914190-26-000113

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.